Y. Yen

发表

Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Frontiers in Oncology.

Ultrasound is highly specific in diagnosing compensated cirrhosis in chronic hepatitis C patients in real world clinical practice

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, Medicine.

Chronic hepatitis B exhibited higher rate of hepatocellular carcinoma occurrence than hepatitis C in cirrhotic patients after effective antiviral treatment.

Chien-Hung Chen, Y. Chiu, Jing-Houng Wang, 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

Association of amino acid variations in the NS5A and E2‐PePHD region of hepatitis C virus 1b with hepatocellular carcinoma

T. Hu, Y. Yen, Sn Lu, 2007, Journal of viral hepatitis.

Dynamic α-fetoprotein, platelets and AST-to-platelet ratio index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapy.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, The Journal of antimicrobial chemotherapy.

The role of HBV genotype, core promoter and precore mutations in advanced liver disease in renal transplant recipients.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2009, Journal of hepatology.

Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients.

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan.

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2009, Vaccine.

Clinical characteristics and prognosis of HCC occurrence after antiviral therapy for HCV patients between sustained and non-sustained responders.

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World Practice

T. Hu, Kuo-Chin Chang, Y. Yen, 2016, PloS one.

Comparison of tenofovir and entecavir in the development of acute kidney injury in cirrhotic chronic hepatitis B patients with refractory ascites.

T. Hu, Kuo-Chin Chang, Y. Yen, 2020, European journal of gastroenterology & hepatology.

Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection

Chien-Hung Chen, Chao-Hung Hung, T. Hu, 2019, BMC Cancer.

Preoperative predictors of non-transplantable recurrence after resection for early-stage hepatocellular carcinoma: application in an East Asian cohort

Chi-Chih Wang, Yueh-Wei Liu, C. Yong, 2022, Updates in Surgery.

The association between steatosis and diabetes with hepatocellular carcinoma in non‐genotype 3 chronic hepatitis C patients

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Association between PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma in Asian chronic hepatitis C patients: A longitudinal study.

Sheng-Nan Lu, Chien-Hung Chen, Chao-Min Huang, 2017, Journal of the Formosan Medical Association = Taiwan yi zhi.

The correlation of controlled attenuation parameter results with ultrasound-identified steatosis in real-world clinical practice.

T. Hu, Kuo-Chin Chang, Jung-Fu Chen, 2017, Journal of the Formosan Medical Association = Taiwan yi zhi.

Serum proteome predicts virological response in chronic hepatitis C genotype 1b patients treated with pegylated interferon plus ribavirin.

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2015, Journal of the Formosan Medical Association = Taiwan yi zhi.

Sorafenib use in hepatitis B virus‐ or hepatitis C virus‐related hepatocellular carcinoma: A propensity score matching study

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, The Kaohsiung journal of medical sciences.

Prognosis after resection of single large hepatocellular carcinoma: Results from an Asian high-volume liver surgery center

Chi-Chih Wang, Yueh-Wei Liu, C. Yong, 2020, PloS one.

A novel evidence of serial changes of bone mineral density in chronic hepatitis B patients treated with entecavir

Chien-Hung Chen, S. Chiu, Jing-Houng Wang, 2021, Hepatology International.

A scoring system to predict HBsAg seroclearance in hepatitis B and C coinfected patients treated with interferon and ribavirin in an Asian cohort

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2018, Medicine.

Contrast-enhanced ultrasonographic spoke-wheel sign in hepatic focal nodular hyperplasia.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2006, European journal of radiology.

The Pre- and Postoperative FIB-4 Indexes Are Good Predictors to the Outcomes of HBV-Related HCC Patients after Resection

T. Hu, Kuo-Chin Chang, Y. Yen, 2019, Gastroenterology research and practice.

A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.

Sheng-Nan Lu, Hsiu-Hsi Chen, Chien-Hung Chen, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match-control study.

T. Hu, K. Chiu, Y. Yen, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference

Sheng-Nan Lu, Chien-Hung Chen, H. Ou, 2019, Digestive Diseases and Sciences.

Decreased anti‐hepatitis C virus titer and associated factors in chronic hepatitis C patients after sustained virological response: A prospective study

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2012, Journal of gastroenterology and hepatology.

Concurrent Sorafenib and Radiotherapy versus Radiotherapy Alone for Locally Advanced Hepatocellular Carcinoma: A Propensity-Matched Analysis

Yao-Hsu Yang, E. Huang, Y. Yen, 2020, Journal of hepatocellular carcinoma.

Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma

Y. Tsai, Chi-Chih Wang, Yueh-Wei Liu, 2020, BMC Cancer.

Reappraisal of the roles of alpha-fetoprotein in hepatocellular carcinoma surveillance using large-scale nationwide database and hospital-based information.

Sheng-Nan Lu, Chien-Hung Chen, Yi‐Hsiang Huang, 2022, Journal of the Formosan Medical Association = Taiwan yi zhi.

Predictors of Virological Suppression After Clinical Relapse in Patients Who Discontinued Entecavir or Tenofovir

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Digestive Diseases and Sciences.

Liver stiffness measurement at complete virological response in hepatoma prediction for HBV‐related cirrhosis patient with potent antiviral agent

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, The Kaohsiung journal of medical sciences.

Comparing the efficacy and clinical outcome of telbivudine and entecavir naïve patients with hepatitis B virus‐related compensated cirrhosis

Chien-Hung Chen, Chuan‐Mo Lee, Chao-Hung Hung, 2014, Journal of gastroenterology and hepatology.

Study of hepatitis B (HB) vaccine non‐responsiveness among health care workers from an endemic area (Taiwan)

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2005, Liver international : official journal of the International Association for the Study of the Liver.

Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy

Sheng-Nan Lu, Chien-Hung Chen, C. Cho, 2017, Medicine.

Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience.

T. Hu, K. Chiu, Y. Chou, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Telbivudine and adefovir combination therapy for patients with chronic lamivudine-resistant hepatitis B virus infections

T. Hu, Kuo-Chin Chang, Hsien‐Chung Yu, 2013, Archives of Virology.

A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2012, The Journal of antimicrobial chemotherapy.

Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts.

Chien-Te Lee, Chao-Hung Hung, T. Hu, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Contrast‐Enhanced Ultrasonography in Hepatic Angiomyolipoma

Sheng-Nan Lu, C. Changchien, Jing-Houng Wang, 2005, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Elevated body mass index is a risk factor associated with possible liver cirrhosis across different etiologies of chronic liver disease.

Chien-Hung Chen, Jing-Houng Wang, T. Hu, 2017, Journal of the Formosan Medical Association = Taiwan yi zhi.

Changes in serum hepatitis B e antigen (HBeAg) levels associated with the emergence of YMDD mutants in HBeAg non‐seroconverted patients during lamivudine therapy

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2007, Liver international : official journal of the International Association for the Study of the Liver.

The therapeutic response of antiviral therapy in HBsAg-positive renal transplant recipients and a long-term follow-up

Chao-Hung Hung, T. Hu, Kuo-Chin Chang, 2012, Hepatology International.

Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus

Sheng-Nan Lu, Chien-Hung Chen, Y. Chiu, 2016, International journal of cancer.

Anemia associated with antiviral therapy in chronic hepatitis C: incidence, risk factors, and impact on treatment response

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2006, Liver international : official journal of the International Association for the Study of the Liver.

Acquirement and disappearance of HBsAg and anti‐HCV in an aged population: a follow‐up study in an endemic township

Kow-Tong Chen, Sheng-Nan Lu, Chien-Hung Chen, 2011, Liver international : official journal of the International Association for the Study of the Liver.

A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis C after sustained response to pegylated interferon and ribavirin combination therapy.

Sheng-Nan Lu, Chien-Hung Chen, M. Yen, 2012, The Journal of antimicrobial chemotherapy.

Three‐year efficacy and safety of tenofovir in nucleos(t)ide analog‐naïve and nucleos(t)ide analog‐experienced chronic hepatitis B patients

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, Journal of gastroenterology and hepatology.

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2018, PloS one.

Liver Interleukin-8 Messenger RNA Expression and Interferon Sensitivity-Determining Region Mutations Relate to Treatment Response in Hepatitis C 1B

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2011, Antiviral therapy.

Predicting Hepatic Steatosis in Living Liver Donors Via Controlled Attenuation Parameter.

T. Hu, Kuo-Chin Chang, Y. Yen, 2018, Transplantation proceedings.

Incorporating albumin-bilirubin grade and up-to-seven criteria to predict outcomes of patients with intermediate stage hepatocellular carcinoma after transarterial (chemo)embolization.

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Journal of the Formosan Medical Association = Taiwan yi zhi.

Suppressor of cytokine signaling 1 expression in peripheral blood mononuclear cells of hepatitis C genotype 1 patients.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, Journal of the Formosan Medical Association = Taiwan yi zhi.

Mutations in the interferon sensitivity‐determining region (nonstructural 5A amino acid 2209–2248) in patients with hepatitis C‐1b infection and correlating response to combined therapy of pegylated interferon and ribavirin

T. Hu, Y. Yen, C-H Chen, 2007, Alimentary pharmacology & therapeutics.

Natural course of hepatic focal nodular hyperplasia: A long‐term follow‐up study with sonography

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2009, Journal of clinical ultrasound : JCU.

MicroRNA-122 as a predictor of HBsAg seroclearance in hepatitis B and C dual infected patients treated with interferon and ribavirin

Sheng-Nan Lu, Chien-Hung Chen, C. Cho, 2016, Scientific Reports.

Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection.

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2010, World journal of gastroenterology.

Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2023, Diagnostics.

Favorable α‐fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablation

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2010, Journal of gastroenterology and hepatology.

Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, PloS one.

Clinical and novel application of FibroScan, FIB‐4 and aspartate aminotransferase‐to‐platelet ratio index in liver fibrosis evaluation in patients with hepatocellular carcinoma and their roles in oesophageal variceal prediction

Sheng-Nan Lu, Chi-Chih Wang, Jing-Houng Wang, 2020, International journal of clinical practice.

Stationary Trend in Elevated Serum Alpha-Fetoprotein Level in Hepatocellular Carcinoma Patients

Yueh-Wei Liu, T. Hu, K. Kee, 2023, Cancers.

Role of hepatitis C virus substitutions and interleukin‐28B polymorphism on response to peginterferon plus ribavirin in a prospective study of response‐guided therapy

T. Hu, Kuo-Chin Chang, Chih‐Ming Liang, 2013, Journal of viral hepatitis.

Changing prevalence of anti-hepatitis A virus in adolescents in a rural township in Taiwan.

Sheng-Nan Lu, Jing-Houng Wang, Jung‐Ta Kao, 2010, Chang Gung medical journal.

Tumor Necrosis Is an Indicator of Poor Prognosis Among Hepatoma Patients Undergoing Resection.

Chi-Chih Wang, Yueh-Wei Liu, C. Yong, 2023, The Journal of surgical research.

Microscopic vascular invasion may not be associated with survival of patients undergoing resection for solitary hepatoma of ≤ 2 cm

Chi-Chih Wang, Yueh-Wei Liu, C. Yong, 2023, PloS one.

Alpha-Fetoprotein Combined with Radiographic Tumor Burden Score to Predict Overall Survival after Liver Resection in Hepatocellular Carcinoma

Yueh-Wei Liu, C. Yong, Y. Yen, 2023, Cancers.

The characteristics of patients with macrovascular invasion in hepatocellular carcinoma: when East meets West

Sheng-Nan Lu, Chi-Chih Wang, Yu-Fan Cheng, 2021, Langenbeck's Archives of Surgery.

Preoperative predictors of early recurrence after resection for hepatocellular carcinoma.

Sheng-Nan Lu, Chi-Chih Wang, Yueh-Wei Liu, 2021, American journal of surgery.

Validation of an alpha-fetoprotein model to predict recurrence after liver resection for hepatocellular carcinoma

Chi-Chih Wang, Yueh-Wei Liu, C. Yong, 2021, Updates in Surgery.

The Role of Protease-Activated Receptor 2 in Hepatocellular Carcinoma after Hepatectomy

Yueh-Wei Liu, C. Hsiao, Chih-Chien Yao, 2021, Medicina.

Characteristics and prognosis of patients with large well-differentiated hepatocellular carcinoma who have undergone resection.

Chien-Hung Chen, Chi-Chih Wang, Yueh-Wei Liu, 2021, American journal of surgery.

Liver resection in elderly patients with hepatocellular carcinoma: age does matter

Chi-Chih Wang, Yueh-Wei Liu, C. Yong, 2021, Updates in Surgery.

Six months as a cutoff time point to define early recurrence after liver resection of hepatocellular carcinoma based on post-recurrence survival

Chi-Chih Wang, Yueh-Wei Liu, C. Yong, 2020, Updates in Surgery.

Microscopic portal vein invasion is a powerful predictor of prognosis in patients with hepatocellular carcinoma who have undergone liver resection

Chi-Chih Wang, Yueh-Wei Liu, C. Yong, 2020, Journal of surgical oncology.

Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high‐volume liver surgery center in East Asia

Chien-Hung Chen, Chi-Chih Wang, Yueh-Wei Liu, 2020, Journal of surgical oncology.

Primary cultures of aspiration residual specimens predict outcomes of hepatocellular carcinoma patients receiving curative treatment

Jing-Houng Wang, M. Yeh, Chung‐Feng Huang, 2020, The Kaohsiung journal of medical sciences.

Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study

T. Hu, Kuo-Chin Chang, Jung-Fu Chen, 2017, PloS one.

Causes of Death among Patients with Hepatocellular Carcinoma According to Chronic Liver Disease Etiology

Yueh-Wei Liu, T. Hu, K. Kee, 2023, Cancers.

Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan.

Ming‐Luen Hu, S. Chuah, T. Hu, 2015, World journal of gastroenterology.

Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival

Sheng-Nan Lu, Chao-Long Chen, Chi-Chih Wang, 2008, Journal of Gastroenterology.

Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2020, PloS one.

Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Frontiers in Oncology.

Transient elastography as a screening tool for liver fibrosis in a large hemodialysis population

T. Hu, Kuo-Chin Chang, Jung-Fu Chen, 2017, Scientific Reports.

Overall survival among patients who undergo resection does not differ significantly between T1a and T1b hepatocellular carcinoma based on the 8^th American Joint Commission on Cancer

Yueh-Wei Liu, C. Yong, H. Eng, 2023, Langenbeck's Archives of Surgery.

Peripheral blood toll-like receptor 4 correlates with rapid virological response to pegylated-interferon and ribavirin therapy in hepatitis C genotype 1 patients

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, BMC Gastroenterology.

Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, PloS one.

Hepatocellular Carcinoma Surveillance at 4- vs. 12-Month Intervals for Patients With Chronic Viral Hepatitis: A Randomized Study in Community

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2013, The American Journal of Gastroenterology.

Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C

Sheng-Nan Lu, Chien-Hung Chen, C. Cho, 2017, PloS one.

The influence of direct-acting antivirals in hepatitis C virus related hepatocellular carcinoma after curative treatment

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, Investigational New Drugs.

A Predictive Scoring Model for Relapse in Chronic HCV Patients with Rapid Virologic Response to PEG Interferon / Ribavirin Treatment

Chien-Hung Chen, T. Hu, Kuo-Chin Chang, 2019 .

The validation of the 2010 American Association for the Study of Liver Diseases guideline for the diagnosis of hepatocellular carcinoma in an endemic area

Chi-Chih Wang, Yu-Fan Cheng, H. Eng, 2015, Journal of gastroenterology and hepatology.

Modifiable Prognostic Factors of Hepatocellular Carcinoma in Patients with Non-Surgical Treatment

Sheng-Nan Lu, Chien-Hung Chen, Yu-Fan Cheng, 2015, PloS one.

Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis C

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2019, PloS one.

Does Nucleos(t)ide Analogues Treatment Affect Renal Function in Chronic Hepatitis B Patients Who Have Already Decreased eGFR? A Longitudinal Study

Chien-Hung Chen, Chao-Hung Hung, T. Hu, 2016, PloS one.

Minimally invasive surgery versus percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma: Results from a high-volume liver surgery center in East Asia.

Sheng-Nan Lu, Chien-Hung Chen, Chi-Chih Wang, 2022, Surgical oncology.

Liver stiffness‐based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy

Sheng-Nan Lu, Chien-Hung Chen, Chuan‐Mo Lee, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Community‐based screening for hepatocellular carcinoma in elderly residents in a hepatitis B‐ and C‐endemic area

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2011, Journal of gastroenterology and hepatology.

Reply to the Letter to the Editor regarding Elevated body mass index is a risk factor associated with possible liver cirrhosis across different etiologies of chronic liver disease: More questions than answer?

T. Hu, Y. Yen, 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Sheng-Nan Lu, Chien-Hung Chen, Jing-Houng Wang, 2021, Frontiers in Oncology.

Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication

Ming‐Luen Hu, Keng-Liang Wu, S. Chuah, 2015, BioMed research international.

Adherence to the modified Barcelona Clinic Liver Cancer guidelines: Results from a high-volume liver surgery center in East Asias

Chien-Hung Chen, Chi-Chih Wang, Yu-Fan Cheng, 2021, PloS one.

Real world clinical practice in treating advanced hepatocellular carcinoma: When East meets West

Chien-Hung Chen, Yueh-Wei Liu, C. Yong, 2020, PloS one.

A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients.

C. Changchien, T. Hu, Y. Huang, 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Incidence and associated risk factors of hepatocellular carcinoma in a dural hepatitis B and C virus endemic area: A surveillance study

Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, 2011, The Kaohsiung journal of medical sciences.